FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2946568609> ?p ?o ?g. }

• W2946568609 endingPage "528" @default.
• W2946568609 startingPage "518" @default.
• W2946568609 abstract "Resveratrol (RES), a non-flavonoid polyphenol extracted from a wide variety of plants, exhibits neuroprotective activities against Parkinson's disease (PD). However, undesirable water solubility of RES reduces its oral bioavailability and demonstrates low efficacy in blood and brain, thus limiting its application. In present study, a nanocrystal formulation of RES (RES-NCs) was developed to enhance its oral bioavailability and delivery into brain for PD treatment. RES-NCs were fabricated with hydroxypropyl methylcellulose (HPMC) stabilizer via antisolvent precipitation approach. The obtained RES-NCs displayed the particle size of 222.54 ± 1.66 nm, the PDI of 0.125 ± 0.035, the zeta potential of -9.41 ± 0.37 mV, and a rapid in vitro dissolution rate. Molecular dynamics simulation of RES and HPMC revealed an interaction energy of -68.09 kJ/mol and a binding energy of -30.98 ± 0.388 kJ/mol, indicating that the spontaneous binding between the two molecules is through van der Waals forces. RES-NCs conferred enhanced cellular uptake as well as improved permeability relative to pure RES. In addition, RES-NCs were able to protect neurons against cytotoxicity induced by MPP+. Meanwhile, RES-NCs exerted no significant toxic effects on zebrafish embryos and larvae, and did not influence their survival and hatching rates. When orally administered to rats, RES-NCs exhibited more favorable pharmacokinetics than pure RES, with higher plasma and brain concentrations. More importantly, MPTP-induced PD mice showed notable improvements in behavior, attenuated dopamine deficiency, and elevated levels of dopamine and its metabolites after the treatment with RES-NCs. Furthermore, immunoblot analysis revealed that the neuroprotective role of RES-NCs may be at least partially mediated by Akt/Gsk3β signaling pathway. Taken altogether, RES-NCs can serve as a potential treatment modality for PD, offering means of improving RES oral bioavailability and brain accumulation." @default.
• W2946568609 created "2019-05-29" @default.
• W2946568609 creator A5007065939 @default.
• W2946568609 creator A5014642685 @default.
• W2946568609 creator A5021022471 @default.
• W2946568609 creator A5022725393 @default.
• W2946568609 creator A5034176841 @default.
• W2946568609 creator A5043572889 @default.
• W2946568609 creator A5052098657 @default.
• W2946568609 creator A5056766584 @default.
• W2946568609 creator A5085787909 @default.
• W2946568609 creator A5091908162 @default.
• W2946568609 date "2020-07-01" @default.
• W2946568609 modified "2023-10-09" @default.
• W2946568609 title "Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation" @default.
• W2946568609 cites W1964670071 @default.
• W2946568609 cites W1991715802 @default.
• W2946568609 cites W2018561955 @default.
• W2946568609 cites W2038062287 @default.
• W2946568609 cites W2039568446 @default.
• W2946568609 cites W2052562226 @default.
• W2946568609 cites W2052726331 @default.
• W2946568609 cites W2054260281 @default.
• W2946568609 cites W2077128382 @default.
• W2946568609 cites W2095090033 @default.
• W2946568609 cites W2113972541 @default.
• W2946568609 cites W2137276388 @default.
• W2946568609 cites W2145480291 @default.
• W2946568609 cites W2159821105 @default.
• W2946568609 cites W2189070656 @default.
• W2946568609 cites W2192972939 @default.
• W2946568609 cites W2334721119 @default.
• W2946568609 cites W2531603068 @default.
• W2946568609 cites W2549190593 @default.
• W2946568609 cites W2578377241 @default.
• W2946568609 cites W2592553712 @default.
• W2946568609 cites W2622653807 @default.
• W2946568609 cites W2635004014 @default.
• W2946568609 cites W2772064658 @default.
• W2946568609 cites W2774484937 @default.
• W2946568609 cites W2799881782 @default.
• W2946568609 cites W2811394358 @default.
• W2946568609 cites W2884628200 @default.
• W2946568609 cites W2899053410 @default.
• W2946568609 cites W2899188579 @default.
• W2946568609 doi "https://doi.org/10.1016/j.ajps.2019.04.003" @default.
• W2946568609 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7486547" @default.
• W2946568609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32952674" @default.
• W2946568609 hasPublicationYear "2020" @default.
• W2946568609 type Work @default.
• W2946568609 sameAs 2946568609 @default.
• W2946568609 citedByCount "36" @default.
• W2946568609 countsByYear W29465686092019 @default.
• W2946568609 countsByYear W29465686092020 @default.
• W2946568609 countsByYear W29465686092021 @default.
• W2946568609 countsByYear W29465686092022 @default.
• W2946568609 countsByYear W29465686092023 @default.
• W2946568609 crossrefType "journal-article" @default.
• W2946568609 hasAuthorship W2946568609A5007065939 @default.
• W2946568609 hasAuthorship W2946568609A5014642685 @default.
• W2946568609 hasAuthorship W2946568609A5021022471 @default.
• W2946568609 hasAuthorship W2946568609A5022725393 @default.
• W2946568609 hasAuthorship W2946568609A5034176841 @default.
• W2946568609 hasAuthorship W2946568609A5043572889 @default.
• W2946568609 hasAuthorship W2946568609A5052098657 @default.
• W2946568609 hasAuthorship W2946568609A5056766584 @default.
• W2946568609 hasAuthorship W2946568609A5085787909 @default.
• W2946568609 hasAuthorship W2946568609A5091908162 @default.
• W2946568609 hasBestOaLocation W29465686091 @default.
• W2946568609 hasConcept C12554922 @default.
• W2946568609 hasConcept C134018914 @default.
• W2946568609 hasConcept C155574463 @default.
• W2946568609 hasConcept C155672457 @default.
• W2946568609 hasConcept C171250308 @default.
• W2946568609 hasConcept C178790620 @default.
• W2946568609 hasConcept C181389837 @default.
• W2946568609 hasConcept C185592680 @default.
• W2946568609 hasConcept C192562407 @default.
• W2946568609 hasConcept C2776816829 @default.
• W2946568609 hasConcept C2777056448 @default.
• W2946568609 hasConcept C513476851 @default.
• W2946568609 hasConcept C55493867 @default.
• W2946568609 hasConcept C71924100 @default.
• W2946568609 hasConcept C86181022 @default.
• W2946568609 hasConcept C86803240 @default.
• W2946568609 hasConcept C98274493 @default.
• W2946568609 hasConceptScore W2946568609C12554922 @default.
• W2946568609 hasConceptScore W2946568609C134018914 @default.
• W2946568609 hasConceptScore W2946568609C155574463 @default.
• W2946568609 hasConceptScore W2946568609C155672457 @default.
• W2946568609 hasConceptScore W2946568609C171250308 @default.
• W2946568609 hasConceptScore W2946568609C178790620 @default.
• W2946568609 hasConceptScore W2946568609C181389837 @default.
• W2946568609 hasConceptScore W2946568609C185592680 @default.
• W2946568609 hasConceptScore W2946568609C192562407 @default.
• W2946568609 hasConceptScore W2946568609C2776816829 @default.
• W2946568609 hasConceptScore W2946568609C2777056448 @default.
• W2946568609 hasConceptScore W2946568609C513476851 @default.

• next